title: Predictive value of clone-specific CDR3 PCR in high-grade non-Hodgkin's lymphoma: long-term persistence of a clone-specific rearrangement in a patient with secondary high-grade NHL in remission after high-dose therapy.
authors.forename: C
authors.initials: C
authors.lastname: Scholten
authors.forename: B
authors.initials: B
authors.lastname: Hilgarth
authors.forename: M
authors.initials: M
authors.lastname: Hilgarth
authors.forename: U
authors.initials: U
authors.lastname: Jaeger
authors.forename: H T
authors.initials: HT
authors.lastname: Greinix
authors.forename: C
authors.initials: C
authors.lastname: Mannhalter
mesh_terms: D000328:Adult; D016026:Bone Marrow Transplantation; D002999:Clone Cells; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D016393:Lymphoma, B-Cell / Q000188:drug therapy*; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D016133:Polymerase Chain Reaction; D012074:Remission Induction